Table 3.
Study | Risk of bias |
CD36, rs1761667 and HDL-c | |
Dawczynski et al80 | ⊝ |
Madden et al79 | ⊝ |
CD36, rs1761667 and TG | |
Dawczynski et al80 | ⊝ |
Madden et al79 | ⊝ |
CD36, rs1049673 and HDL-c | |
Dawczynski et al80 | ⊝ |
Madden et al79 | ⊝ |
CD36, rs1527483 and TG | |
Zheng et al65 | ⊕ |
Madden et al79 | ⊝ |
ApoE, rs429358, rs7412 and TG | |
AbuMweis et al69 | ⊝ |
Carvalho-Wells et al70 | ⊕ |
Caslake et al71 | ⊕ |
Dang et al72 | ⊕ |
Jackson et al73 | ⊝ |
Minihane et al75 | ⊕ |
Olano-Martin et al76 | ⊕ |
Paschos et al77 | ⊝ |
Thifault et al78 | ⊕ |
ApoE, rs429358, rs7412 and total-c | |
AbuMweis et al69 | ⊝ |
Carvalho-Wells et al70 | ⊕ |
Caslake et al71 | ⊕ |
Dang et al72 | ⊕ |
Fallaize et al54 | ⊝ |
Jackson et al73 | ⊝ |
Minihane et al75 | ⊕ |
Olano-Martin et al76 | ⊕ |
Paschos et al77 | ⊝ |
Thifault et al78 | ⊕ |
31-SNP nutri-GRS and TG | |
Vallée Marcotte et al63 | ⊕ |
Vallée Marcotte et al64 | ⊕ |
PPARg2, rs1801282 and LDL-c | |
Binia et al81 | ⊝ |
Harsløf et al61 | ⊕ |
Itariu et al84 | ⊕ |
Lindi et al85 | ⊝ |
Zheng et al65 | ⊕ |
PPARg2, rs1801282 and total-c | |
Binia et al81 | ⊝ |
Harsløf et al61 | ⊕ |
Itariu et al84 | ⊕ |
Lindi et al85 | ⊝ |
Zheng et al65 | ⊕ |
PPARg2, rs1801282 and TG | |
Binia et al81 | ⊝ |
Harsløf et al61 | ⊕ |
Itariu et al84 | ⊕ |
Lindi et al85 | ⊝ |
Zheng et al65 | ⊕ |
FADS, rs174547 and total-c | |
AbuMweis et al69 | ⊝ |
Alsaleh et al60 | ⊕ |
Lu et al46 | ⊝ |
Standl et al47 | ⊝ |
Dumont et al43 | ⊝ |
Dumont et al44 | ⊝ |
Roke and Mutch67 | ⊝ |
⊕ no serious risk of bias; ⊝ serious risk of bias; ⊝⊝ very serious risk of bias (for study design type using NIH Study Quality Assessment Tools).
GRSs, genetic risk scores; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; SNPs, single nucleotide polymorphisms; TG, triglycerides; total-c, total cholesterol.